LifePlan Financial Group’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$0 Hold
20
﹤0.01% 578
2020
Q2
$0 Hold
20
﹤0.01% 575
2020
Q1
$0 Hold
20
﹤0.01% 555
2019
Q4
$0 Hold
20
﹤0.01% 556
2019
Q3
$0 Hold
20
﹤0.01% 551
2019
Q2
$0 Hold
20
﹤0.01% 549
2019
Q1
$0 Hold
20
﹤0.01% 550
2018
Q4
$0 Hold
20
﹤0.01% 548
2018
Q3
$0 Hold
20
﹤0.01% 540
2018
Q2
$0 Hold
20
﹤0.01% 529
2018
Q1
$0 Buy
+20
New +$345 ﹤0.01% 518
2014
Q2
Sell
-20
Closed 103
2014
Q1
$0 Hold
20
﹤0.01% 267
2013
Q4
$0 Hold
20
﹤0.01% 245
2013
Q3
$0 Hold
20
﹤0.01% 227
2013
Q2
$0 Buy
+20
New +$421 ﹤0.01% 202

Other funds holding DVAX

LifePlan Financial Group's DVAX Position: Q3 2020 in Review

LifePlan Financial Group held its Dynavax Technologies (DVAX) position steady in Q3 2020 at 20 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #578.

LifePlan Financial Group first reported a position in DVAX in Q2 2013 and has held it in 15 quarters since. 165 funds tracked by Wall St. Rank hold DVAX as of Q3 2020.

  • LifePlan Financial Group held 20 shares of Dynavax Technologies worth $0 as of Q3 2020.
  • LifePlan Financial Group left its Dynavax Technologies share count unchanged in Q3 2020.
  • Dynavax Technologies made up ﹤0.01% of LifePlan Financial Group's portfolio in Q3 2020, its #578 holding.
  • LifePlan Financial Group first reported a position in Dynavax Technologies in Q2 2013 and has held it in 15 quarters since.
  • 165 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2020.

Based on LifePlan Financial Group's 13F filing for Q3 2020, filed 30 Oct 2020.